Are type III-IV muscle afferents required for a normal steady-state exercise hyperpnoea in humans?
about
Autonomic responses to exercise: group III/IV muscle afferents and fatigue.Type III-IV muscle afferents are not required for steady-state exercise hyperpnea in healthy subjects and patients with COPD or heart failure.Sympathetic control of reflex cutaneous vasoconstriction in human aging.Reliability of a Novel High Intensity One Leg Dynamic Exercise Protocol to Measure Muscle Endurance.Increasing blood flow to exercising muscle attenuates systemic cardiovascular responses during dynamic exercise in humansThe Physiological Mechanisms of Performance Enhancement with Sprint Interval Training Differ between the Upper and Lower Extremities in Humans.Pathophysiology of human ventilatory control.Muscle adaptation to exercise: New Saltin's paradigms.Translational neurocardiology: preclinical models and cardioneural integrative aspects.Recovery of central and peripheral neuromuscular fatigue after exercise.Task Failure during Exercise to Exhaustion in Normoxia and Hypoxia Is Due to Reduced Muscle Activation Caused by Central Mechanisms While Muscle Metaboreflex Does Not Limit Performance.Career perspective: Jerome A. DempseyReappraisal of systemic venous chemoreceptors: might they explain the matching of breathing to metabolic rate in humans?Influence of muscle metaboreceptor stimulation on middle cerebral artery blood velocity in humans.Central and peripheral hemodynamics in exercising humans: leg vs arm exercise.Mangifera indica L. Leaf Extract in Combination With Luteolin or Quercetin Enhances VO2peak and Peak Power Output, and Preserves Skeletal Muscle Function During Ischemia-Reperfusion in Humans.
P2860
Q35108132-28F4B67D-D44F-432F-8F14-63734F0C578AQ36073977-B65FDCE3-9FDE-4AB6-B812-CC0659FD9A55Q36122763-BA54EC17-02CD-4AE7-9BC4-AA9009E42E9AQ36153721-A42FBF55-16AE-4D5D-9C09-98AB3E8F2437Q36339268-DDBC2633-CD9A-415B-BBE1-85109FE8568FQ37298088-A0F21BD9-E439-4468-9143-F58EA84725D6Q38219952-73E9315D-805B-4587-A4F5-644FD1A9E3D4Q38640639-87224918-38F2-4FFF-9A0D-1442FDC8A6A9Q38813230-EA637918-0990-4754-9E37-0B89D8D1A982Q39033707-D20E55A8-2E89-4F9A-80FA-7090B4B1F672Q42075426-4F102333-A6A2-4189-8D5F-2B42D62609C9Q42722134-4633FA8F-3332-4A93-BCF1-6B7AC7FA1376Q47738497-47C93DCE-E6FD-43AF-862E-BFCC0503131EQ47814850-5A8BE963-F6FE-4414-AB86-B7A69D62C034Q50238848-0D8DDB74-1B17-40F9-BB09-5598BD29C698Q55236619-7A798907-D385-4485-917A-9DDF69CA5289
P2860
Are type III-IV muscle afferents required for a normal steady-state exercise hyperpnoea in humans?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Are type III-IV muscle afferen ...... exercise hyperpnoea in humans?
@en
type
label
Are type III-IV muscle afferen ...... exercise hyperpnoea in humans?
@en
prefLabel
Are type III-IV muscle afferen ...... exercise hyperpnoea in humans?
@en
P2860
P921
P1476
Are type III-IV muscle afferen ...... exercise hyperpnoea in humans?
@en
P2093
Grégory M Blain
Jerome A Dempsey
P2860
P304
P356
10.1113/JPHYSIOL.2013.261925
P407
P50
P577
2013-09-02T00:00:00Z
2014-02-01T00:00:00Z